A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific protein. This is the first application of the new technology, called DNA-encoded monoclonal antibody (DMAb), for cancer immunotherapy. The study was published online in Cancer Immunology, Immunotherapy.
Prostate cancer is the second most common cancer in men worldwide. Traditional treatments are invasive and can impair the quality of life of patients, underscoring the need for alternative therapeutic strategies, including immunotherapy. One of the immunotherapeutic approaches that has been explored thus far relies on the use of monoclonal antibodies that specifically target a protein present on the surface of prostate cancer cells called prostate specific membrane antigen (PSMA) to elicit an anti-tumor immune response and control the cancer. Although promising, this strategy is limited by the production cost required to make these therapeutic antibodies. Additionally, multiple infusions are often required to achieve efficacy.
Wistar researchers devised a novel DNA-based approach in which an engineered DNA plasmid is constructed and used to deliver the instructions to make the desired anti-PSMA antibody so that the therapy can be generated in the patient’s body in a sustained manner. This research has important implications for the use of DNA-encoded monoclonal antibody technology as a platform for delivering the next generation of immunotherapies for cancer and many human diseases.
“This is an important demonstration of the possibilities opened up for immunotherapy by DMAb technology to direct in vivoproduction of antibodies of major relevance to human cancer,” said David B. Weiner, Ph.D., executive vice president of The Wistar Institute, director of The Wistar Institute Vaccine & Immunotherapy Center, W.W. Smith Charitable Trust Professor in Cancer Research, and senior author of the study. “There is a great need for such new approaches for prostate disease as well as many other cancers. As recent data suggest, PSMA is an important cancer antigen expressed on many human prostate, bladder, renal as well as ovarian cancers, so additional study of the possible benefits of this therapy are important.”
The new technology was tested in mice for the ability to generate antibodies in their blood stream that would target human PSMA as well as target PSMA-positive tumors. Results showed that antibodies were able to bind to the cancer cells and recruited specific immune cells called natural killer cells, resulting in shrinkage of the tumor, significantly improving survival.
“Our data provide proof of concept that DMAb engineered DNA plasmids can be successfully used to target important cancers,” said Kar Muthumani, M.Sc., Ph.D., assistant professor in the Translational Tumor Immunology Program at Wistar, member of the Vaccine & Immunotherapy Center and lead author of the study. “The unique features of our synthetic DNA-based system make it a promising novel approach for cancer therapy, alone or in combination with other treatments.”
The Latest on: Synthetic DNA
- GenScript Launches Enhanced GenBrick Gene Synthesis Service for Building Synthetic Genomeson June 25, 2019 at 4:43 am
Service enables synthesis of DNA sequences up to 200kb with 100 percent sequence accuracy PISCATAWAY, N.J., June 25, 2019 /PRNewswire/ -- GenScript®, the world's leading gene synthesis provider ... […]
- DNA 3D Printing Market Key Opportunities, Application and Forecast to 2024 : Key Players: Arevo, Cambrian Genomics, Imaginarium, 3D Systemson June 24, 2019 at 10:46 am
It is made for printing the human genome at much simpler methods as compared to the traditional method of DNA synthesis. The process of DNA 3D printing includes millions of strands that are formed ... […]
- Cells Shimmer Like a Thousand Ice Cream Sprinkles in Gorgeous New 'DNA Microscope' Imageson June 21, 2019 at 5:58 am
For instance, in the study the researchers showed that DNA microscopy could map the locations of individual human cancer cells in a sample. These synthetic DNA tags can even help scientists map the ... […]
- DNA Microscope Sees ‘Through the Eyes of the Cell’on June 20, 2019 at 12:42 pm
A scientist starts by pipetting readily available chemical reagents onto a sample. This causes small, synthetic DNA tags to latch on to biomolecules inside the cells. A subsequent reaction leads each ... […]
- Use of synthetic DNA spike-in controls (sequins) for human genome sequencingon June 19, 2019 at 10:08 am
Next-generation sequencing (NGS) has been widely adopted to identify genetic variants and investigate their association with disease. However, the analysis of sequencing data remains challenging ... […]
- We should create a global DNA threat-detection network to fight future pathogenson June 19, 2019 at 9:00 am
Today, geneticist George Church weighs in with his thoughts and opinions on synthetic biology and a world-wide "DNA detector" net. Tomorrow we'll have a guest post from microbiologist Andrew Hessel. ... […]
- Researchers develop new method for deriving 3-D protein structures from lab-designed DNA sequences, mutant geneson June 17, 2019 at 8:18 am
Searching for a better way, Marks and her colleagues from Harvard Medical School, the Dana-Farber Cancer Institute and the Broad Institute turned to mutational libraries—synthetic DNA sequences ... […]
- Synthetic Biology Market revenue to hit $55 billion by 2025: Global Market Insights, Inc.on June 13, 2019 at 4:03 am
Amyris, GenScript, DNA2.0, Evolva, DSM, Integrated DNA technologies, Twist biosciences, Editas Medicine, Inc., Pareto Biotechnologies, Blue heron, TeselaGenSyntrox Inc, and Thermo Fischer Scientific ... […]
- MOF-encapsulated DNA for gene therapyon June 13, 2019 at 12:08 am
The researchers report their findings in Advanced Materials("Encapsulation of Plasmid DNA by Nanoscale Metal–Organic Frameworks for Efficient Gene Transportation and Expression") Schematic ... […]
- Submicrometer elasticity of double-stranded DNA revealed by precision force-extension measurements with magnetic tweezerson June 12, 2019 at 11:06 am
This design also simplified the synthesis of hairpin-containing tether because the construct could be prepared in a single PCR step using a primer with a preformed hairpin motif, instead of ligating ... […]
via Google News and Bing News